from Stocks-Markets-Economic Times https://ift.tt/2YO2oj0
Home »
Stocks-Markets-Economic Times
» Brokerages’ views mixed on Glenmark Pharma
Brokerages’ views mixed on Glenmark Pharma
from Stocks-Markets-Economic Times https://ift.tt/2YO2oj0
Related Posts:
Sebi confirms ban on 5 persons in Zee insider trading caseThe regulator said a detailed investigation in the matter is in progress which may bring out additional roles of omission or commission, of these five persons, if any, in detail. from Stocks-Markets-Economic Times https://if… Read More
Reliance Industries m-cap goes past Rs 16 lakh cr mark at close of tradeThe market heavyweight gained 1.70 per cent to close at Rs 2,525.20 on the BSE. During the day, it jumped 1.85 per cent to its record high of Rs 2,529. from Stocks-Markets-Economic Times https://ift.tt/3m1fi7L … Read More
Standard Life to sell 5% stake in HDFC AMC on WednesdayHDFC AMC operates as a joint venture between Housing Development Finance Corporation (HDFC) and Standard Life Investments. As of June 30, 2021, Standard Life held a 21.23 per cent stake in the mutual fund house, while HDFC ow… Read More
Videocon case: Sebi slaps Rs 75 lakh fine on Venugopal Dhoot, two entities"Noticees being insiders had executed off market transactions while in possession of Unpublished Price Sensitive Information (UPSI)," Sebi said. from Stocks-Markets-Economic Times https://ift.tt/2XTAynt … Read More
Two major block deals worth Rs 6,017 crore were executed on WednesdayStandard Life, which held a 21.23 per cent stake in HDFC AMC, sold 5 per cent of total equity at Rs 2873.79 per share on BSE to raise Rs 3,061 crore. from Stocks-Markets-Economic Times https://ift.tt/3F3oEZm … Read More
0 Comments:
Post a Comment